Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to trace how rising rates hit Columbia Financial’s net interest margin or when directors last bought shares? Community banks pack hundreds of pages of regulatory detail into every filing, and Columbia Financial, Inc. (CLBK) is no exception.
Our platform turns those dense documents into clear answers. Stock Titan’s AI reads each submission the second it hits EDGAR, so you receive Columbia Financial Form 4 insider transactions real-time alerts instead of hunting through exhibits. Dive into a concise dashboard where:
- 10-Ks & 10-Qs decoded: The engine delivers a plain-English breakdown of interest income, loan loss provisions, and segment performance—Columbia Financial annual report 10-K simplified and every Columbia Financial quarterly earnings report 10-Q filing distilled in minutes.
- Form 4 tracking: Instantly spot Columbia Financial executive stock transactions Form 4 and monitor buying or selling trends with AI context.
- 8-K event clarity: Whether it’s a branch acquisition or a sudden credit-loss update, get Columbia Financial 8-K material events explained without legal jargon.
Common searches such as “Columbia Financial SEC filings explained simply” or “understanding Columbia Financial SEC documents with AI” lead here because we answer them directly. You can also explore the Columbia Financial proxy statement executive compensation section to see how leadership pay aligns with community-bank performance, and our engine provides concise Columbia Financial earnings report filing analysis.
From rate-sensitive margin tables to Columbia Financial insider trading Form 4 transactions, every disclosure is summarized, searchable, and delivered in real time—so analysts, portfolio managers, and community investors spend time making decisions, not turning pages.
Randall Elizabeth E., a director of Columbia Financial, Inc. (CLBK) reported transactions dated 08/08/2025. She acquired 172.1333 phantom common stock units under the Columbia Bank Stock Based Deferral Plan at $14.33 per unit; those units will be settled in shares upon distribution. The filing also shows a disposition of 39,934 common shares and indirect holdings of 44,447 shares in an IRA, 6,704 in a Roth IRA, and 3,207 via Stock Award IV. She holds 62,474 exercisable stock options (exercise price $15.60) granted 07/23/2020 that expire 07/23/2029. Stock Awards vest on March 11, 2026. Form signed by Dennis E. Gibney, POA, on 08/12/2025.
Jennings William Justin, EVP and Director at Columbia Financial, Inc. (CLBK), reported multiple stock-based transactions and holdings. On 08/08/2025 he acquired 3,126.226 phantom stock units under the Bank's Stock Based Deferral Plan at an implied price of $14.33; those units will be settled in shares upon distribution. The report also discloses indirect holdings of 3,116 shares via an ESOP, 608 via a SERP, 7,795 from a Stock Award II and 7,533 from a Stock Award III. Option positions include 41,475 options at $21.79 (fully vested, exercisable through 03/21/2032), 5,715 options at $16.49 (vesting begins 03/06/2025, exp. 03/06/2034) and 13,051 options at $16.23 (vesting begins 03/03/2026, exp. 03/03/2035).
Columbia Financial EVP & CHRO Jenifer White reported insider transactions dated 08/08/2025 involving common stock, deferred units and several equity awards. The filing records an acquisition of phantom stock units under the Columbia Bank Stock Based Deferral Plan at $14.33 per unit to be settled in shares, and a reported disposition of 3,352 common shares.
The filing also discloses multiple indirect holdings through an ESOP, SERP, SIM and several stock awards that vest over time or upon performance, plus four separate option grants exercisable into common stock with strikes of $20.54, $15.94, $16.49 and $16.23 and expirations in 2032–2035. These entries reflect compensation-related awards and long-term incentives rather than an extraordinary market action.
Kemly Thomas J., who serves as President & CEO and a director of Columbia Financial, Inc. (CLBK), reported insider transactions dated 08/08/2025. The filing shows a disposition of 233,808 common shares and the purchase of 124.7125 phantom stock units under the company’s rabbi trust at a price of $14.33 per unit; those phantom units are to be settled in shares upon distribution. Following the reported transactions, the filing lists 65,320.1776 shares beneficially owned, many held indirectly through plans including a 401(k), ESOP, SERP, spouse, and multiple stock award vehicles.
The report also discloses outstanding stock option positions granted under the 2019 Equity Incentive Plan: 656,471 options at $15.60 (fully vested, exp. 07/23/2029), 37,894 at $15.94 (exp. 05/01/2033), 37,168 at $16.49 (exp. 03/06/2034), and 94,749 at $16.23 (exp. 03/03/2035). Several stock awards include time- and performance-based vesting conditions described in the filing.
Columbia Financial, Inc. reported improved core earnings for the quarter ended June 30, 2025. Net income was $12.3 million for the quarter and $21.2 million for the six months, compared with $4.5 million and $3.4 million in the prior-year periods, driven by higher net interest income of $53.7 million in the quarter (up from $44.1 million) and lower interest expense on borrowings. Loans receivable grew to $8.18 billion from $7.92 billion at year-end, and total assets rose to $10.74 billion. Stockholders' equity increased to $1.1207 billion.
Key risk and liquidity items are visible in the quarterly statements: debt securities available for sale carried significant unrealized losses (approximately $98.8 million), non-accrual loans increased to $39.5 million from $21.7 million, and the company used $289.3 million in investing cash flows while increasing borrowings to $1.273 billion. The allowance for credit losses rose to $64.5 million. Overall, results show stronger profitability and balance sheet growth but with heightened credit and investment-mark-to-market pressures.
Columbia Financial (CLBK) – Form 4 insider filing
President & CEO Thomas J. Kemly acquired 127.0176 common shares on 07/25/2025 at $14.07 under the non-discretionary Columbia Bank Stock-Based Deferral Plan (code “A”). No shares were sold.
Post-transaction holdings: 233,808 shares held directly; 187,742 shares across 401(k), ESOP, SERP, SIM and spouse; 154,383 performance/ time-based stock awards; 65,195 shares in the deferral plan. Kemly also reports 826,282 stock options with exercise prices of $15.60-$16.49 expiring 2029-2035.
The purchase is modest (~$1.8 k) relative to existing ownership and was executed automatically, offering limited incremental signal to investors.
Columbia Financial, Inc. (CLBK) – Form 4 insider filing
Senior EVP & Chief Risk Officer John Klimowich reported a minor acquisition on 07/25/2025. Via the Columbia Bank Stock-Based Deferral Plan he was credited with 45.3727 phantom stock units at $14.07 each (≈ $0.6 k). Phantom units convert to common shares upon distribution; no open-market activity was disclosed.
Post-transaction ownership
- Direct: 60,769 common shares.
- Indirect: 7,678.8499 phantom units (deferral plan), 17,130 (401-k), 7,620 (ESOP), 7,051 (SERP), 4,214 (SIM) and 37,572 share equivalents from incentive stock awards.
- Derivatives: 229,425 option shares across four grants, strike prices $15.60-$16.49, expiring 2029-2035; 188,235 options are already fully vested.
FAQ
What is the current stock price of Columbia Financ (CLBK)?
What is the market cap of Columbia Financ (CLBK)?
